MaxCyte
MXCT
MXCT
115 hedge funds and large institutions have $198M invested in MaxCyte in 2025 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 39 increasing their positions, 44 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
115
Holders Change
-4
Holders Change %
-3.36%
% of All Funds
1.56%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
12
Increased
39
Reduced
44
Closed
14
Calls
$1K
Puts
–
Net Calls
+$1K
Net Calls Change
-$56K
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$7.08M |
| 2 |
GA
Gagnon Advisors
New York
|
+$2.55M |
| 3 |
Chevy Chase Trust
Bethesda,
Maryland
|
+$2.43M |
| 4 |
GS
Gagnon Securities
New York
|
+$2.32M |
| 5 |
CCM
Cadian Capital Management
New York
|
+$1.87M |
Top Sellers
| 1 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
-$4.72M |
| 2 |
Millennium Management
New York
|
-$3.72M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$1.05M |
| 4 |
Goldman Sachs
New York
|
-$634K |
| 5 |
Swedbank
Stockholm,
Sweden
|
-$573K |
